SCHEMBL7239607

SCHEMBL7239607

C(CCN1CCOCC1)CN1CCOCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.71
ALDH1A1 P00352 2/20 0.56
KDM4E B2RXH2 2/20 0.56
HPGD P15428 1/20 0.56
DUSP3 P51452 1/20 0.56
SIGMAR1 Q99720 2/20 0.54
POLB P06746 2/20 0.54
GLA P06280 1/20 0.50
KDM1A O60341 2/20 0.48
HRH3 Q9Y5N1 2/20 0.48
GAA P10253 1/20 0.48
CYP1A2 P05177 1/20 0.48
CHRM2 P08172 1/20 0.48
CHRM1 P11229 1/20 0.48
HTR2A P28223 1/20 0.48
MAPK1 P28482 1/20 0.48
SCN1A P35498 1/20 0.48
HTR2B P41595 1/20 0.48
KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9740021 0.97 KEAP1 (0.68) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL7103406 0.97 KEAP1 (0.68) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL16173592 0.97 KEAP1 (0.68) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL9738476 0.97 KEAP1 (0.68) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL11609926 0.97 KEAP1 (0.68) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL1998867 0.94 KEAP1 (0.71) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL17377315 0.92 KEAP1 (0.62) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL11222517 0.91 KEAP1 (0.68) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
Ammonia Solution, Strong SCHEMBL9400430 0.91 KEAP1 (0.68) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD
SCHEMBL235080 0.90 KDM4E (0.65) KEAP1SMN1; SMN2ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577412-B2 Corrosion inhibiting coating compositions PRC-DESOTO INTERNATIONAL, INC. (US) 2026-03-17 US claimed
US-20240174867-A1 CORROSION INHIBITING COATING COMPOSITIONS PRC-DESOTO INTERNATIONAL, INC. (US) 2024-05-30 US claimed
EP-4301817-A1 CORROSION INHIBITING COATING COMPOSITIONS PRC-Desoto International, Inc. (US) 2024-01-10 EP claimed
CN-117321150-A Corrosion inhibiting coating composition PRC-迪索托国际公司 2023-12-29 CN claimed
WO-2022187845-A1 CORROSION INHIBITING COATING COMPOSITIONS PRC-DESOTO INTERNATIONAL, INC. (US) 2022-09-09 WO claimed
US-12577412-B2 Corrosion inhibiting coating compositions PRC-DESOTO INTERNATIONAL, INC. (US) 2026-03-17 US disclosed
WO-2025151695-A1 COATING COMPOSITIONS COMPRISING MAGNESIUM OXIDE AND A LITHIUM COMPOUND PRC-DESOTO INTERNATIONAL, INC. (US) 2025-07-17 WO disclosed
US-20240174867-A1 CORROSION INHIBITING COATING COMPOSITIONS PRC-DESOTO INTERNATIONAL, INC. (US) 2024-05-30 US disclosed
EP-4301817-A1 CORROSION INHIBITING COATING COMPOSITIONS PRC-Desoto International, Inc. (US) 2024-01-10 EP disclosed
CN-117321150-A Corrosion inhibiting coating composition PRC-迪索托国际公司 2023-12-29 CN disclosed
WO-2022187845-A1 CORROSION INHIBITING COATING COMPOSITIONS PRC-DESOTO INTERNATIONAL, INC. (US) 2022-09-09 WO disclosed
US-7217447-B2 Ink-jet recording sheet FUJIFILM CORPORATION (JP) 2007-05-15 US disclosed
US-6583133-B1 Especially against Gram-positive organisms, e.g. methicillin-sensitive (MSSA) and methicillin- resistant (MRSA) staphylococci, enterococci and pneumococci BASILEA PHARMACEUTICA AG (CH) 2003-06-24 US disclosed
EP-1090013-A1 PROPENYL CEPHALOSPORIN DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-04-11 EP disclosed
WO-1999067255-A1 PROPENYL CEPHALOSPORIN DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-12-29 WO disclosed
US-5120731-A For use as oxygen carriers in blood substitutes KALIE-CHEMIE AG (DE) 1992-06-09 US disclosed
US-4070416-A POLYFUNCTIONAL ISOCYANATES AND EPOXIDES, ISOCYANURATE-OXAZOLIDOLE POLYMERS HITACHI, LTD. (JA) 1978-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577412-B2 Corrosion inhibiting coating compositions MGMT, MBD2, MECP2 KEAP1 2569/4885SMN1; SMN2 2878/4885ALDH1A1 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.